Thierry Alcindor: Patterns of Response of dMMR or High-TMB Sarcomas to ICI Treatment
3h agoen
From the article
Thierry Alcindor, Senior Physician at Dana-Farber Cancer Institute and Harvard Medical School, shared a post on X: “In this paper, I and colleagues from Dana Farber News and Brigham and […]
Continue reading on OncoDailyYou might also wanna read
A Multicenter Randomized Open-Label Trial Evaluating MRD-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.
clinicaltrials.gov·1d ago
Short-Course Radiotherapy Followed by CAPOX With or Without Iparomlimab and Tuvonralimab in pMMR/MSS Locally Advanced Rectal Cancer
clinicaltrials.gov·1d ago
Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma
clinicaltrials.gov·7d ago
Predictors of BCR After RARP for Localized Prostate Cancer: A Retrospective Analysis
clinicaltrials.gov·3d ago
The immunology of human breast cancer
doi.org·18d ago
Gut microbiome composition predicts melanoma recurrence risk in patients on immunotherapy, large trial finds
This study analyzed stool samples from 674 patients with resected high-risk melanoma enrolled in the phase 3 CheckMate 915 clinical trial to
cell.com·12d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.